Vizgen and Scale Biosciences Unveil Strategic Partnership at AGBT

Vizgen, Inc., the life science company dedicated to improving human health by visualizing single-cell spatial genomics information, has announced a partnership with Scale Biosciences (ScaleBio) to combine their single-cell and spatial technologies for enhanced data analysis at the Advances in Genome Biology and Technology (AGBT) 2024 General Meeting in Orlando, Florida.

Agre wins Next Gen Leadership Award at AGBT 2024

Agre PaterneIITA-CGIAR Molecular Breeder Scientist, joined IITA in 2016 as a postdoctoral fellow and consultant. He has since served in the Yam Breeding Unit of IITA, contributing groundbreaking results in breeding, data analysis, and optimized root tuber solutions to farmers. He currently focuses on applying biological information and molecular tools to support yam breeding.

Highlights from AGBT 2024 – Part I

The 24th event of the Advances in Genome Biology and Technology (AGBT) General Meeting kicked off in Orlando this week. As usual, the meeting was jam-packed with the release of new and upgraded technologies, high-quality research presentations, and late-night festivities for networking and letting off some steam. No one article can encompass all of the great content shown at the meeting, so we’ll cover some highlights in two articles with a clear summary in the final installment.

Elinor Karlsson

Elinor Karlsson, PhD, is associate professor in Bioinformatics and Integrative Biology at the UMass Chan Medical School, and director of Vertebrate Genomics at the Broad Institute of MIT and Harvard. Her research combines new technology, community science and genomics to investigate diseases and discover the origins of exceptional mammalian traits. Dr. Karlsson’s research includes the Zoonomia project, an international effort to compare the genomes of over 240 mammals (from the African Yellow-spotted Rock Hyrax to the Woodland Dormouse), to identify segments of DNA that are important for survival and health. Dr. Karlsson has a special interest in dog genetics, and her international Darwin’s Ark project invites all dog owners to enroll their dogs in an open data research project exploring the genetic basis of behavior, as well as diseases such as cancer.

Elinor received her B.A. in biochemistry/cell biology and her B.F.A. (Bachelor of Fine Arts) from Rice University, and earned her Ph.D. in bioinformatics from Boston University. She was a postdoctoral fellow with Pardis Sabeti at Harvard University before starting her research group at UMass Chan in 2014.